Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | US

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
WILLIS LEASE FINANCE CORP Leasing and financing commercial jet engines and aircraft for airlines, OEMs, and MROs globally.	United States of America	WLFC
Wise birds Inc. Ad-tech agency optimizing digital ad campaigns for businesses of all sizes with targeted solutions.	South Korea	273060
WooDeumGee Farm Co., Ltd Provides smart farm solutions across the entire value chain, from tech to crop distribution.	South Korea	403490
WOOJUNG BIO, Inc. Integrated R&D platform offering CRO services, lab construction, and biotech incubation.	South Korea	215380
WPP plc A global network providing advertising, PR, media management, and data analytics services.	United States of America	WPP
WPP PLC Global leader in advertising and marketing, providing AI-powered solutions for top brands.	United Kingdom	WPP
Xenetic Biosciences, Inc. Advancing DNase & CAR T immune-oncology platforms to treat hard-to-treat cancers.	United States of America	XBIO
Xilio Therapeutics, Inc. Engineering tumor-activated biologics for cancer to maximize efficacy and minimize toxicity.	United States of America	XLO
XLMEDIA PLC A former performance marketing company for the sports and gaming industries.	Jersey	XLM
XORTX Therapeutics Inc. Developing late-stage, uric acid-lowering therapies for gout and progressive kidney disease.	United States of America	XRTX